Aurobindo Pharma Announcements
Intimation of incorporation of a wholly owned step-down subsidiary in Malaysia.
17 Sep, 2025 | 05:24pm • Source: BSE
Submission of Clarification Letter on significant movement in Volume of shares
12 Sep, 2025 | 02:25pm • Source: BSE
The Exchange has sought clarification from Aurobindo Pharma Ltd on September 12, 2025, with reference to Movement in Volume. <BR><BR>The reply is awaited.
12 Sep, 2025 | 01:21pm • Source: BSE
Submission of Voting Results of 38th AGM along with Scrutinizer Report.
11 Sep, 2025 | 05:33pm • Source: BSE
Submission of Proceedings of 38th AGM of the Company held on September 10, 2025.
10 Sep, 2025 | 05:52pm • Source: BSE
Intimation of completion of US FDA Inspection at Unit-XII of Aurobindo Pharma Limited
05 Sep, 2025 | 06:41pm • Source: BSE
Submission of notice published in newspapers.
02 Sep, 2025 | 11:35am • Source: BSE
Intimation of Completion of US FDA inspection at Unit-1 of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company.
29 Aug, 2025 | 10:03pm • Source: BSE
Update on entering into a binding agreement for transfer of shares of Curateq Biologics s.r.o by Helic Healthcare B.V to Curateq Biologics B.V, wholly owned...
29 Aug, 2025 | 04:02pm • Source: BSE
Intimation of investor meeting on 04.09.2025.
29 Aug, 2025 | 12:06pm • Source: BSE
Intimation of investor meeting on 03.09.2025.
29 Aug, 2025 | 12:03pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about receipt of approval for Dazublys biosimilar from UK s MHRA by CuraTeQ Biologics
26 Aug, 2025 | 09:50am • Source: NSE
Intimation of receipt approval for biosimilar Dazyblys from UK''s MHRA by Curateq Biologics s.r.o a wholly owned step-down subsidiary of the Company.
26 Aug, 2025 | 09:40am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
20 Aug, 2025 | 12:18pm • Source: NSE
Submission of notice published in newspapers regarding IEPFA 100 days campaign "Saksham Niveshak".
20 Aug, 2025 | 11:56am • Source: BSE
Submission of clarification on news item appearing in media titled "Aurobindo closing in on $5.5 billion Zentiva Buyout.
20 Aug, 2025 | 11:13am • Source: BSE
Confirmation of dispatch of letters to shareholders who have not registered their email ids, providing weblink for Integrated Annual Report 2024-25.
19 Aug, 2025 | 05:58pm • Source: BSE
Intimation of investor meeting to be held on August 20, 2025.
12 Aug, 2025 | 06:11pm • Source: BSE
Intimation of 38th Annual General Meeting of the Company to be held on September 10, 2025.
12 Aug, 2025 | 11:57am • Source: BSE
Submission of transcript of earnings call on the Unaudited Financial Results for the first quarter ended June 30. 2025.
08 Aug, 2025 | 12:07pm • Source: BSE